Coreg and HSRs-Updated Analysis

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Hypersensitivity
Interventions
DRUG

Carvedilol immediate release only

All dosages of carvedilol immediate release

DRUG

Carvedilol extended release only

All dosages of carvedilol extended release

DRUG

Long acting β-blockers

All dosages of LA propranolol and SA metoprolol

DRUG

Other α1/β-adrenergic antagonists

i.e., labetalol. All dosages. Excluding carvedilol immediate release and carvedilol extended release.

DRUG

Short acting Non-selective β-blockers and short acting β1-Selective agents

All dosages of short acting non-selective β-Blockers (Carteolol, Levobunolol, Metipranolol, Nadolol, Penbutolol, Pindolol, Sotalol, Timolol) and short acting β1-Selective agents (Acebutolol, Atenolol, Betaxolol, Bisoprolol, Nebivolol)

OTHER

No β-blocker

No β-blocker within the month prior to the index date

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01316952 - Coreg and HSRs-Updated Analysis | Biotech Hunter | Biotech Hunter